Gene | Score gda | Association Type | Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
|
0.450 | Biomarker | disease | BEFREE | Taken together, these results define novel APRIL actions via TACI on Tregs and Bregs to promote MM cell survival, providing the rationale for targeting APRIL/TACI system to alleviate the immunosuppressive BM milieu and improve patient outcome in MM. | 30135465 | 2019 | ||||
|
0.450 | GeneticVariation | disease | GWASCAT | Genome-wide association study identifies multiple susceptibility loci for multiple myeloma. | 27363682 | 2016 | ||||
|
0.450 | GeneticVariation | disease | GWASCAT | Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. | 23955597 | 2013 | ||||
|
0.450 | GeneticVariation | disease | GWASDB | Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. | 23955597 | 2013 | ||||
|
0.450 | Biomarker | disease | CTD_human | Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk. | 23955597 | 2013 | ||||
|
0.450 | AlteredExpression | disease | BEFREE | The aim of this study was to further characterize the role of TACI expression in MM DESIGN AND METHODS: Using gene expression profiling, we investigated whether these patterns are kept in TACI+ or TACI- HMCL. | 17550853 | 2007 | ||||
|
0.450 | GeneticVariation | disease | BEFREE | FISH analyses of these patients identified one MM carrying a 3.8 Mb amplified region and two MMs with gains specifically involving the TACI locus. | 17823926 | 2007 | ||||
|
0.450 | Biomarker | disease | BEFREE | This set makes it possible to efficiently classify TACI(hi) and TACI(lo) MMCs in an independent cohort of 40 patients. | 15827134 | 2005 | ||||
|
0.450 | AlteredExpression | disease | LHGDN | Expression of BCMA, TACI, and BAFF-R by MM taken together with the ability of BLyS to support MM cell growth and survival has exciting implications because they may be potential therapeutic targets. | 14512299 | 2004 |